PROTOKOLwiki
COMPOUNDS / ADAPTOGEN / ELEUTHERO
ADAPTOGEN

ELEUTHERO

LOW RISK
BEST FOR:Stress & Fatigue●●●●●●●○○○7/10
ELEUTHERO · ELEUTHEROCOCCUS SENTICOSUS · SIBERIAN GINSENG · ACANTHOPANAX SENTICOSUS · CIWUJIA · SIBERIAN ELEUTHERO · TOUCH-ME-NOT
AdaptogenAntioxidantNootropicTraditional Chinese MedicineSoviet / RussianAnti-fatigue

Adaptogenic root from Northeast Asia used to enhance stress resistance, endurance, and immune function

ROUTE / DOSAGE
LOW300mg
STANDARD500-1000mg
HIGH2000mg+
Note: Standardized extract; take in morning to avoid sleep disruption
CYCLE
3 months on 2-4 weeks off recommended to prevent tolerance
BIOAVAILABILITY
Variable oral bioavailability of eleutherosides estimated 20-40%
ACTIVE DURATION
4-8h (subjective)
STORAGE
Cool dry place away from direct sunlight liquid extracts refrigerated after opening
HALF-LIFE
Not well characterized eleutherosides estimated 2-4h (plasma)
DURATION BREAKDOWN
Total4-8 hours (acute); cumulative effects over weeks
Onset1-2h
Come up30-60 min
Peak2-4h
Offset2-4h
After effects4-8h
Duration varies by route, dose, and individual. Source: community reports.
§ 01 — EFFECTS
6 documented
Reduced fatigue and improved stamina
Enhanced stress resistance
Improved cognitive function and memory
Immune system support
Anti-inflammatory activity
Neuroprotective effects
§ 02 — RISKS
Insomnia if taken late in day due to stimulant properties
Potential interactions with anticoagulants and antiplatelet drugs
Mild gastrointestinal discomfort at high doses
May affect blood pressure in hypertensive individuals
Allergic reactions in sensitive individuals
§ 03 — INTERACTIONS
Interaction data not yet available for this compound.
§ 04 — SCIENCE

Eleutherococcus senticosus has been extensively studied in vitro and in vivo for adaptogenic, neuroprotective, antidiabetic, and anticancer properties. Evidence supports anti-fatigue and stress-resistance effects, with demonstrated modulation of oxidative stress and inflammatory pathways. Neuroprotective potential has been shown in models of Alzheimer's, Parkinson's, and cerebral ischemia, though most data is preclinical. Anticancer activity has been demonstrated in glioblastoma and lung/liver cancer models via ferroptosis induction. Human clinical trial data remains limited and heterogeneous, with many studies using mixed herbal formulations. Conservation concerns exist as the plant is endangered in some regions of its natural range.

§ 06 — SOURCES
[1]
Eleutherococcus senticosus: An Important Adaptogenic Plant
pubmed.ncbi.nlm.nih.gov ↗
[2]
Acanthopanax senticosus: Photochemistry and Anticancer Potential
pubmed.ncbi.nlm.nih.gov ↗
[3]
Biotechnological production of eleutherosides: current state and perspectives
pubmed.ncbi.nlm.nih.gov ↗
[4]
Pharmacological effects of Eleutherococcus senticosus on the neurological disorders
pubmed.ncbi.nlm.nih.gov ↗
[5]
Molecular Mechanisms of Ferroptosis Induced by Eleutherococcus senticosus in Glioblastoma
pubmed.ncbi.nlm.nih.gov ↗
Disclaimer. Protokol.wiki is an informational reference. Nothing on this site is medical advice. Compounds listed may be unapproved, unregulated, or illegal in your jurisdiction. Consult a licensed physician before use. Data compiled from peer-reviewed literature.
METHODOLOGYCONTRIBUTECONTACT